Suzuki M - Search Results

1

Establishment of a new extrahepatic bile duct carcinoma cell line, TFK-1.

Saijyo S, Kudo T, Suzuki M, Katayose Y, Shinoda M, Muto T, Fukuhara K, Suzuki T, Matsuno S. Saijyo S, et al. Among authors: suzuki m, suzuki t. Tohoku J Exp Med. 1995 Sep;177(1):61-71. doi: 10.1620/tjem.177.61. Tohoku J Exp Med. 1995. PMID: 8693487 Free article.

2

A new in vitro model of specific targeting therapy of cancer: retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma.

Saijyo S, Kudo T, Katayose Y, Saeki H, Chiba N, Suzuki M, Tominaga T, Matsuno S. Saijyo S, et al. Among authors: suzuki m. Tohoku J Exp Med. 1996 Feb;178(2):113-27. doi: 10.1620/tjem.178.113. Tohoku J Exp Med. 1996. PMID: 8727693 Free article.

3

MUC1-specific targeting immunotherapy with bispecific antibodies: inhibition of xenografted human bile duct carcinoma growth.

Katayose Y, Kudo T, Suzuki M, Shinoda M, Saijyo S, Sakurai N, Saeki H, Fukuhara K, Imai K, Matsuno S. Katayose Y, et al. Among authors: suzuki m. Cancer Res. 1996 Sep 15;56(18):4205-12. Cancer Res. 1996. PMID: 8797593

4

Effective adoptive immunotherapy by T-LAK cells retargeted with bacterial superantigen-conjugated antibody to MUC1 in xenografted severe combined immunodeficient mice.

Shinoda M, Kudo T, Suzuki M, Katayose Y, Sakurai N, Saeki H, Kodama H, Fukuhara K, Imai K, Hinoda Y, Matsuno S. Shinoda M, et al. Among authors: suzuki m. Cancer Res. 1998 Jul 1;58(13):2838-43. Cancer Res. 1998. PMID: 9661899

5

Establishment of an activated macrophage cell line, A-THP-1, and its properties.

Tominaga T, Suzuki M, Saeki H, Matsuno S, Tachibana T, Kudo T. Tominaga T, et al. Among authors: suzuki m. Tohoku J Exp Med. 1998 Oct;186(2):99-119. doi: 10.1620/tjem.186.99. Tohoku J Exp Med. 1998. PMID: 10223614 Free article.

6

Specific targeting immunotherapy of cancer with bispecific antibodies.

Kudo T, Suzuki M, Katayose Y, Shinoda M, Sakurai N, Kodama H, Ichiyama M, Takemura S, Yoshida H, Saeki H, Saijyo S, Takahashi J, Tominaga T, Matsuno S. Kudo T, et al. Among authors: suzuki m. Tohoku J Exp Med. 1999 Aug;188(4):275-88. doi: 10.1620/tjem.188.275. Tohoku J Exp Med. 1999. PMID: 10598685 Free article. Review.

7

Mutated SEA-D227A-conjugated antibodies greatly enhance antitumor activity against MUC1-expressing bile duct carcinoma.

Kodama H, Suzuki M, Katayose Y, Shinoda M, Sakurai N, Takemura S, Yoshida H, Saeki H, Ichiyama M, Tsumoto K, Asano R, Kumagai I, Imai K, Hinoda Y, Matsuno S, Kudo T. Kodama H, et al. Among authors: suzuki m. Cancer Immunol Immunother. 2001 Dec;50(10):539-48. doi: 10.1007/s002620100219. Cancer Immunol Immunother. 2001. PMID: 11776376

8

Perineural tumor invasion and its relation with the lymphogenous spread in human and experimental carcinoma of bile duct. A computer-aided 3-D reconstruction study.

Suzuki M, Takahashi T, Ouchi K, Matsuno S. Suzuki M, et al. Tohoku J Exp Med. 1994 Jan;172(1):17-28. doi: 10.1620/tjem.172.17. Tohoku J Exp Med. 1994. PMID: 8036618 Free article.

9

[Undifferentiated sarcoma of the liver].

Suzuki M, Matsuno S. Suzuki M, et al. Ryoikibetsu Shokogun Shirizu. 1995;(7):302-5. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749478 Japanese. No abstract available.

10

[Sarcomatoid carcinoma].

Fukuhara K, Suzuki M, Matsuno S. Fukuhara K, et al. Among authors: suzuki m. Ryoikibetsu Shokogun Shirizu. 1995;(7):504-6. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749538 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,133 results

Search Page